Jürg Meier, Ph.D.
Jürg Meier, Ph.D. is the Chairman of the Board of Directors. Dr. Jürg Meier consults entrepreneurs and start-up companies. He was the executive Director of the Novartis Venture Fund for eight years. Previously, he was working over 25 years in various international management functions of the former company Sandoz Pharma Ltd., Head of R&D Biochemie GmbH Austria, Head of R&D Sandoz USA and worldwide, President of Sandoz Pharma Japan. During eight years he was a member of the Swiss National Science Foundation and supervised three NCCR programs (National Centers of Competence in Research). Dr. Jürg Meier is also Chairman of Cardiolynx AG and a Board Member of BioMed Invest AG and Solvias AG.
